The race to find medical treatments for Covid-19—and future pandemics—is on, driving renewed investments by the healthcare and pharmaceutical industries in Real-World Data (RWD) and Real-World Evidence (RWE). A new report on AI and the real-world studies industry, from Deep Pharma Intelligence (DPI), Evomics Medical and The Yuan (an online forum focused on AI in healthcare, for which I am a contributor), provides fresh insights into this rapidly evolving patient-centric approach to increasing R&D efficiency, accelerating the introduction of new drugs, and improving health outcomes. Full Story:
Category: health – Page 199
TRU Community Care in Lafayette was the host to the unveiling of a brand new technology in the medical field — a humanoid robot that can perform basic medical tasks.
Beyond Imagination, an AI company based out of Colorado Springs, visited the Lafayette hospice center to test out the robot, named BEOMNI.
“We are excited that TRU sees the almost limitless potential of our humanoid robots in health care and has agreed to run this first pilot study with us. We look forward to partnering with them to bring a highly effective solution to market,” said inventor and CEO Dr. Harry Kloor.
The Indian edtech giant Byju’s keeps getting bigger, having raised more than $4.5 billion since it was founded 10 years ago. This month the company made clear its ambitious research agenda: to achieve the science-fiction dream of building next-generation teaching aids with artificial intelligence.
Specifically, the company announced a new research-and-development hub, with offices in Silicon Valley, London and Bangalore, that will work on applying the latest findings from artificial intelligence and machine learning to new edtech products. The new hub, called Byju’s Lab, will also work on “moonshots” of developing new forms of digital tutoring technology, said Dev Roy, chief innovation and learning officer for BYJU’s, in a recent interview with EdSurge.
“Edtech is one of the slowest adopters of AI so far, compared to some of the other industries out there,” Roy said. “Even in health care, what DeepMind has done with mapping the proteins of DNA—nobody’s doing that in the education sector.”
“It is not known at this time whether the variant is more transmissible, or more dangerous to the health of those who catch it, than other coronavirus variants.”
There are two confirmed cases of the omicron variant of the coronavirus in Ottawa, the Ontario government announced Sunday.
“Today, the province of Ontario has confirmed two cases of the omicron variant of COVID-19 in Ottawa, both of which were reported in individuals with recent travel from Nigeria. Ottawa Public Health is conducting case and contact management and the patients are in isolation,” the statement said.
How will future AI systems make the most ethical choices for all of us?
Artificial intelligence is already making decisions in the fields of business, health care, and manufacturing. But AI algorithms generally still get help from people applying checks and making the final call.
What would happen if AI systems had to make independent decisions and ones that could mean life or death for humans?
Unlike humans, robots lack a moral conscience and follow the “ethics” programmed into them. At the same time, human morality is highly variable. The “right” thing to do in any situation will depend on who you ask.
For the first time, researchers appear to have effectively treated a genetic disorder by directly injecting a CRISPR therapy into patients’ bloodstreams — overcoming one of the biggest hurdles to curing diseases with the gene editing technology.
The therapy appears to be astonishingly effective, editing nearly every cell in the liver to stop a disease-causing mutation.
The challenge: CRISPR gives us the ability to correct genetic mutations, and given that such mutations are responsible for more than 6,000 human diseases, the tech has the potential to dramatically improve human health.
Walmart has launched an instant drone delivery system for customers living within a 50-mile radius of its headquarters in northern Arkansas.
The retail giant has partnered with drone company Zipline to launch the new system that will offer on-demand delivery for health and wellness and consumable items within 50 miles of the Walmart Neighborhood Market in Pea Ridge, according to a press release.
“It’s unbelievably exciting, we’ve been working towards this day for many many years,” Zipline’s CEO Liam O’Connor told CBS News.
Keisha S., a health and energy coach from the Caribbean nation of Antigua and Barbuda, just won a free trip to suborbital space with Virgin Galactic.
Scientists in South Africa are warning of a new strain of COVID-19. The variant, which is yet to be named, appears to have a high number of mutations, and there’s a possibility it could be able to evade our immune response and be even more transmissible.
At first, health officials thought they were seeing a small cluster of outbreaks in South Africa’s most populous province. But after examining specimens, they realized they were dealing with something far more serious — a new variant that could be the hardest yet to contain.
Officials are worried that the new variant, known simply as B.1.1.529, could quickly spread through the country and beyond. Only about 35% of adults in South Africa are fully vaccinated, and the rate of vaccination has slowed. And given the findings so far, even current vaccines may not be enough to stop it.
Several countries, including the UK and Germany have announced a ban on flights from South Africa and five neighboring countries as cases of the new variant have already appeared in Botswana and in Hong Kong. No matter where the variant started, it could quickly become a global problem.
Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1
For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews.
►Instagram: https://www.instagram.com/dwnews.
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch.
#Covid19 #NewVariant #SouthAfrica
Tesla CEO Elon Musk vended about$1.05 billion in stock on Tuesday evening, according to fiscal forms posted this week. The deals were listed in September to exercise options that were set to expire in 2022.Musk has vended a aggregate of$9.85 billion in Tesla stock this month including the$6.9 billion he vended the week ofNov.10 and another$1.9 billion he vended onNov. 15 andNov. 16. Some of the shares were vended in part to satisfy duty scores related to an exercise of stock options. Musk and his trust still hold further than 169 million shares in the company.
Tesla shares fell15.4 the week endedNov.12 marking the worst week for Tesla stock in 20 months after Musk began dealing shares. Shares of Tesla were over about 1 on Wednesday autumn. Musk ran an informal Twitter bean onNov.6 asking his further than 60 million Twitter followers whether or not he should vend 10 of his Tesla stock. The bean eventually ended with druggies telling Musk to vend.
But Musk had formerly indicated before this time he was likely to vend a huge block of his options in the fourth quarter. During an appearance at the Code Conference in September he said when his stock options expire at Tesla his borderline duty rate would be over 50.